These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12744905)

  • 1. Novel configurations of high molecular weight species of the pertussis toxin vaccine component.
    Fowler S; Byron O; Jumel K; Xing D; Corbel MJ; Bolgiano B
    Vaccine; 2003 Jun; 21(19-20):2678-88. PubMed ID: 12744905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
    Seubert A; D'Oro U; Scarselli M; Pizza M
    Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies.
    Ibsen PH
    Vaccine; 1996 Apr; 14(5):359-68. PubMed ID: 8735545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
    Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
    Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
    Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
    Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
    Kamachi K; Konda T; Arakawa Y
    Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
    Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity.
    Fowler S; Xing DK; Bolgiano B; Yuen CT; Corbel MJ
    Vaccine; 2003 Jun; 21(19-20):2329-37. PubMed ID: 12744863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterisation of the pertussis vaccine.
    Ceccarini C; Contorni M; Costantino P; D'Ascenzi S; Gallo E; Maffei M; Mannucci D; Marsili I; Magagnoli C; Peppoloni S; Rappuoli R; Ravenscroft N; Ricci S
    Dev Biol (Basel); 2000; 103():175-88. PubMed ID: 11214235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.
    Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I
    Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering bacterial toxin for the development of new vaccine against pertussis.
    Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody that neutralizes pertussis toxin activities.
    Pootong A; Budhirakkul P; Tongtawe P; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):37-45. PubMed ID: 17891920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.
    Cropley I; Douce G; Roberts M; Chatfield S; Pizza M; Marsili I; Rappuoli R; Dougan G
    Vaccine; 1995 Dec; 13(17):1643-8. PubMed ID: 8719514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment.
    Nencioni L; Volpini G; Peppoloni S; Bugnoli M; De Magistris T; Marsili I; Rappuoli R
    Infect Immun; 1991 Feb; 59(2):625-30. PubMed ID: 1702767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.
    Peppoloni S; Pizza M; De Magistris MT; Bartoloni A; Rappuoli R
    Physiol Chem Phys Med NMR; 1995; 27(4):355-61. PubMed ID: 8768791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of microcalorimetry to characterize tetanus neurotoxin, pertussis toxin and filamentous haemagglutinin.
    Krell T; Greco F; Nicolaï MC; Dubayle J; Renauld-Mongénie G; Poisson N; Bernard I
    Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):241-51. PubMed ID: 12911336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
    Nascimento IP; Dias WO; Quintilio W; Christ AP; Moraes JF; Vancetto MD; Ribeiro-Dos-Santos G; Raw I; Leite LC
    Microbes Infect; 2008 Feb; 10(2):198-202. PubMed ID: 18248757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.